MBAYX
Price
$13.73
Change
+$0.05 (+0.37%)
Updated
Jul 25 closing price
Net Assets
89.32M
RLBCX
Price
$36.95
Change
+$0.07 (+0.19%)
Updated
Jul 25 closing price
Net Assets
253.86B
Interact to see
Advertisement

MBAYX vs RLBCX

Header iconMBAYX vs RLBCX Comparison
Open Charts MBAYX vs RLBCXBanner chart's image
MassMutual Balanced Svc
Price$13.73
Change+$0.05 (+0.37%)
VolumeN/A
Net Assets89.32M
American Funds American Balanced R3
Price$36.95
Change+$0.07 (+0.19%)
VolumeN/A
Net Assets253.86B
MBAYX vs RLBCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MBAYX vs. RLBCX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MBAYX is a Buy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 254B vs. MBAYX (89.3M). RLBCX pays higher dividends than MBAYX: RLBCX (1.57) vs MBAYX (1.25). MBAYX was incepted earlier than RLBCX: MBAYX (28 years) vs RLBCX (23 years). MBAYX (1.02) is less costly to investors than RLBCX (0.89). MBAYX is a more actively managed with annual turnover of: 130.00 vs. RLBCX (44.00). MBAYX has a lower initial minimum investment than RLBCX: MBAYX (0) vs RLBCX (250). RLBCX annual gain was more profitable for investors over the last year : 9.89 vs. MBAYX (5.36). RLBCX return over 5 years is better than : 37.80 vs. MBAYX (14.51).
MBAYXRLBCXMBAYX / RLBCX
Total Expense Ratio1.020.89115%
Annual Report Gross Expense Ratio1.020.89115%
Fund Existence28 years23 years-
Gain YTD5.0698.83057%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets89.3M254B0%
Annual Yield % from dividends1.251.5780%
Returns for 1 year5.369.8954%
Returns for 3 years27.8533.6583%
Returns for 5 years14.5137.8038%
Returns for 10 years25.9762.1342%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PHAT9.630.58
+6.41%
Phathom Pharmaceuticals
WBA11.610.02
+0.17%
Walgreens Boots Alliance
HTGC19.440.01
+0.05%
Hercules Capital
CHNR3.75-0.02
-0.53%
China Natural Resources Inc
LPTH3.06-0.14
-4.38%
LightPath Technologies